Confo Therapeutics vs KSQ Therapeutics, Inc.
Confo Therapeutics
Exploiting the conformational complexity of GPCRs to innovate drug discovery
84 employees · est. 2015 · Zwijnaarde, Belgium
KSQ Therapeutics, Inc.
The company is deploying CRISPRomics for novel drug development across broad therapeutic areas and is currently advancing a proprietary pipeline of tumor- and immune-focused drug candidates
60 employees · est. 2015 · Lexington, United States
Side-by-Side Comparison
| Metric | Confo Therapeutics | KSQ Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2015 |
| Headquarters | ||
| Headquarters | Zwijnaarde, Belgium | Lexington, United States |
| Employees | ||
| Employees | 84 | 60 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biopharma, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Grant | Series C |
| Total Funding | ||
| Total Funding | Not tracked yet | $166.00M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 4 |
| Services | ||
| Services | Development of GPCR-modulating therapies, Clinical research and development, Partnership with pharmaceutical companies, Small molecules and antibody therapeutics development, GPCR targeting technology innovation | CRISPRomics Platform, Cancer Drug Development, Pipeline Advancements, Partnerships for Drug Development |
| Target Customers | ||
| Target Customers | Patients with metabolic diseases, Patients with endocrine diseases, Pharmaceutical companies, Healthcare providers specializing in pain management, Research institutions | Healthcare Providers, Cancer Patients, Research Institutions, Pharmaceutical Companies |
| Taxonomy | ||
| Taxonomy | GPCR Drug DiscoveryConformational StabilizationBiopharmaceuticalsDrug Candidates DevelopmentSevere Illness TherapeuticsDisease-Modifying Treatments +9 | CRISPRomicsDrug DevelopmentFunctional GenomicsTumor-focused TherapiesImmune-focused TherapiesGenome-scale Precision +9 |
| Website | ||
| Website | confotherapeutics.com | ksqtx.com |
About Confo Therapeutics
Confo Therapeutics, founded in 2015 and headquartered in Belgium, is a pioneering biotechnology company that leverages its proprietary technology platform to stabilize functional conformations of GPCRs (G protein-coupled receptors). This innovative approach uncovers a vast array of previously inacce...
About KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. stands as a pioneering entity in the biopharmaceutical industry, leveraging its industry-leading CRISPRomics platform to revolutionize drug development. Based in Cambridge, Massachusetts, the company focuses on pinpointing therapeutic nodes that directly correlate genomic func...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Confo Therapeutics and KSQ Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Confo Therapeutics or KSQ Therapeutics, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Confo Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Confo Therapeutics on 15 Jun 2026, and KSQ Therapeutics, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
